First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - OOSTERHOUT PHARMA-BIOTECH CONSULTING LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: OOSTERHOUT PHARMA-BIOTECH CONSULTING LTD, 136 HERTFORD ROAD, ENFIELD, MIDDLESEX, EN3 5AX. The legal status is a Private Limited Company and the current status at the registry of companies is Liquidation. The last filed accounts are dated 30 September 2020. The company was incorporated on 19 September 2019.

The accounts next due date is 30 June 2022. There are no mortgages.

The above was based on public record information as at 19 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 12215627
Date Incorporated: 19 September 2019
Date Latest Accounts: 30 September 2020
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 12215627
Annual Return: Unknown
Registered Office: 136 HERTFORD ROAD, ENFIELD, MIDDLESEX, EN3 5AX
SIC Code and Operations: 74909
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

OOSTERHOUT PHARMA-BIOTECH CONSULTING LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 29 September 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09435077 OOSTERHOUTSE HANDELS MAATSCHAPPIJ BEHEER LIMITED Active - Proposal to Strike off
09435135 OOSTERHOUTSE HANDELS MAATSCHAPPIJ LIMITED Active - Proposal to Strike off
13449941 OOSTERINK PROPERTY LTD Active
14561377 OOSTERINK TRADING LTD Active
08590340 OOSTHUIZEN & CO LTD Dissolved

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd